MYLAN 2264 MYLAN 2264 (Terazosin Hydrochloride 2 mg)
Pill with imprint MYLAN 2264 MYLAN 2264 is Black / Purple, Capsule-shape and has been identified as Terazosin Hydrochloride 2 mg. It is supplied by Mylan Pharmaceuticals Inc..
Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 2264 MYLAN 2264
- MYLAN 2264 MYLAN 2264
- 2 mg
- Black / Purple
- 14.00 mm
- Prescription only
- Drug Class
- Antiadrenergic agents, peripherally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
lactose anhydrous, silicon dioxide, D&C Red No. 28, D&C Red No. 33, FD&C Blue No. 1, magnesium stearate, microcrystalline cellulose, corn starch, sodium lauryl sulfate, titanium dioxide, ferrosoferric oxide, ammonia, propylene glycol, shellac, dimethicone
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|00378-2264||Mylan Pharmaceuticals Inc.|
|51079-0937||UDL Laboratories Inc.|
More about terazosin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 41 Reviews
- Drug class: antiadrenergic agents, peripherally acting
- FDA Alerts (1)
Other brands: Hytrin
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.